Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Implementation of Motor Function Measure score percentile curves - Predicting motor function loss in Duchenne muscular dystrophy.
Hafner P, Schmidt S, Schädelin S, Rippert P, Hamroun D, Fabien S, Henzi B, Putananickal N, Rubino-Nacht D, Vuillerot C, Fischer D; MFM registry Study Group. Hafner P, et al. Among authors: schadelin s. Eur J Paediatr Neurol. 2022 Jan;36:78-83. doi: 10.1016/j.ejpn.2021.11.004. Epub 2021 Dec 14. Eur J Paediatr Neurol. 2022. PMID: 34929615 Free article.
Quantitative muscle MRI: A powerful surrogate outcome measure in Duchenne muscular dystrophy.
Bonati U, Hafner P, Schädelin S, Schmid M, Naduvilekoot Devasia A, Schroeder J, Zuesli S, Pohlman U, Neuhaus C, Klein A, Sinnreich M, Haas T, Gloor M, Bieri O, Fischmann A, Fischer D. Bonati U, et al. Among authors: schadelin s. Neuromuscul Disord. 2015 Sep;25(9):679-85. doi: 10.1016/j.nmd.2015.05.006. Epub 2015 Jun 4. Neuromuscul Disord. 2015. PMID: 26096788
Treatment with L-Citrulline in patients with post-polio syndrome: A single center, randomized, double blind, placebo-controlled trial.
Putananickal N, Orsini AL, Schmidt S, Gocheva V, Rubino D, Haas T, Schädelin S, Deligianni X, Bieri O, Fischer D, Hafner P. Putananickal N, et al. Among authors: schadelin s. Neuromuscul Disord. 2021 Nov;31(11):1136-1143. doi: 10.1016/j.nmd.2021.08.011. Epub 2021 Aug 24. Neuromuscul Disord. 2021. PMID: 34711479 Free article. Clinical Trial.
Metabolic markers of short and long-term exogenous DL-beta-hydroxybutyrate supplementation in episodic migraine patients: an exploratory analysis of a randomized-controlled-trial.
Putananickal N, Gross EC, Orsini AL, Schmidt S, Hafner P, Gocheva V, Nagy S, Henzi BC, Rubino D, Schädelin S, Sandor P, Fischer D. Putananickal N, et al. Among authors: schadelin s. Front Pharmacol. 2023 May 4;14:1172483. doi: 10.3389/fphar.2023.1172483. eCollection 2023. Front Pharmacol. 2023. PMID: 37214431 Free PMC article.
Ovarian torsion in children: Development of a predictive score.
Bolli P, Schädelin S, Holland-Cunz S, Zimmermann P. Bolli P, et al. Among authors: schadelin s. Medicine (Baltimore). 2017 Oct;96(43):e8299. doi: 10.1097/MD.0000000000008299. Medicine (Baltimore). 2017. PMID: 29069000 Free PMC article.
Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis.
Disanto G, Barro C, Benkert P, Naegelin Y, Schädelin S, Giardiello A, Zecca C, Blennow K, Zetterberg H, Leppert D, Kappos L, Gobbi C, Kuhle J; Swiss Multiple Sclerosis Cohort Study Group. Disanto G, et al. Among authors: schadelin s. Ann Neurol. 2017 Jun;81(6):857-870. doi: 10.1002/ana.24954. Ann Neurol. 2017. PMID: 28512753 Free PMC article.
41 results